Behzad Aghazadeh

Behzad has more than 20 years of experience in the biopharmaceutical industry, with over 10 years of experience as an institutional investor. He began his career in healthcare as a research scientist, later joining Booz Allen as a management consultant, where he led major strategic and operational initiatives for companies in the pharmaceutical and biotechnology industries. Behzad currently serves as the Chairman of Immunomedics, a clinical-stage biopharmaceutical company developing targeted therapies for the treatment of cancers and other diseases with high unmet medical need. Behzad received his Master’s degree in Physics from the Ludwig-Maximilians-University (Munich, Germany) and a PhD from Cornell University in Biochemistry & Biophysics.